Top Ten most popular articles on Pharmafile.com this week
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s Friday again, and the past week was populated with a host of riveting news and features from the life …
NICE U-turns to recommend Sanofi Gaucher disease drug
June 2, 2017Medical Communications, Sales and Marketing Gaucher disease, NICE, Sanofi
It has been revealed that NICE has reached the decision to recommend Sanofi’s Cerdelga (eligustat) for use on the NHS …
Childhood mortality from diarrhoea falls by third
June 2, 2017Medical Communications Diarhhoea, India, Nigeria
A study has found that the rates of children dying from diarrhoea worldwide fell by a third through the decade …
Clinical Trial Success: How Relationships Are Key
June 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros
Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …
Silence Therapeutics instate new COO
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics
Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …
Europe vs USA: New drug approvals
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, regulatory affairs
Dr Terese Johansson, Regulatory Affairs Consultant NDA Group AB, examines the drop in US approvals while observing no similar trend …
What the life sciences industry wants from the next UK government
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences
The stakes are high as the UK general election draws ever closer, and the industry has come out in force …
New method discovered to target chronic pain
June 1, 2017Research and Development opioid, painkillers
Chronic pain is notoriously difficult to treat and can lead some people to take painkillers of increasing strength to combat …
Mylan overcharged for EpiPen by $1.7 billion, new report says
June 1, 2017Sales and Marketing Mylan, epipen
More bad news for Mylan as a new report from the Department of Health and Human Services’ Office of the …
New biosimilar guidelines launched in the EU
June 1, 2017Medical Communications, Research and Development, Sales and Marketing EMA, biosimilars
A joint effort by the EMA and the European Commission has seen the publication of a biosimilar information guide for …
Ohio takes legal action against pharma companies for opioid crisis
June 1, 2017Medical Communications Ohio, opioid, opioid crisis
If there is one state that needs answers for its citizens’ struggles with opioids, it is Ohio. The state saw …
Navigating the challenges of health technology assessment
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GPI, Global Pricing Innovations
In the face of restricted budgets, payers worldwide are increasingly using Health Technology Assessments (HTAs) as a way of managing …
NLS Pharma reveals data on different kind of ADHD treatment
May 31, 2017Research and Development NLS Pharma, mazindol
Most treatments for ADHD are stimulants, while the two most common treatments Adderall and Ritalin contain amphetamines. Due to the …
Collegium bring in former Biogen SVP as new COO
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Collegium pharmaceutical
Collegium Pharmaceutical has announced the appointment of Joseph Ciaffoni to the position of Executive Vice President and Chief Operating Officer. …
Could robots solve the pharma talent crisis?
May 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, UK, brexit, pharma, talent crisis
Unpredictability in the industry and beyond is rife, but talent acquisition remains a key issue for Pharma and Life Sciences. …
FDA approves first generic versions of Lilly’s ADHD drug
May 31, 2017Research and Development, Sales and Marketing ADHD, Apotex, Aurobindo, FDA, Glenmark, Teva
The FDA has given its approval for the commercialisation of the first-ever generic versions of Eli Lilly’s Strattera (atomoxetine) for …
Evidence of tampering with Valium medication in Australia
May 31, 2017Medical Communications, Research and Development Roche, valium
Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …
Mounting US pricing pressures cutting into quarterly sales, Novartis admits
May 31, 2017Research and Development, Sales and Marketing Novartis, Sandoz
Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …
MSD allays Irish fears with €280m expansion investment
May 31, 2017Manufacturing and Production, Research and Development Ireland, MSD
There were fears in Ireland that President Trump’s strong words to bring manufacturing back to the US would hurt the …
Modified antibiotic shows big promise against drug-resistant bacteria
May 30, 2017Research and Development antibiotic resistance, vancomycin
Scientists at The Scripps Research Institute (TSRI) have succeeded in reengineering vancomycin – a widely-used antibiotic – in order to …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
